Le Lézard
Classified in: Health, Science and technology, Business
Subjects: OTC, STP

The White House's Telehealth Services Program for Veterans Validates Medical Innovation Holdings, Inc. "MIHI" Plan to Provide Specialty Medical Services to Rural Americans


DULUTH, Georgia, August 9, 2017 /PRNewswire/ --

Opens Up A Super-Sized Market That Is Largely Untapped. The Administration has endorsed telemedicine as a solution to support delivery of care. Both VA and MIHI Respectively Are seeking To Expand Access To Veterans & Rural Populations Via Telemedicine; Benefits Include Less Wait time, Little To No Travel and Access To Wide Range Of Specialists

Medical Innovation Holdings, Inc. ("MIHI" or the "Company") (OTC: MIHI), a Company who was the first to focus on providing specialty telemedicine/telehealth services to patients in rural medically underserved areas, today commented on how an August 3, 2017 announcement by the Trump administration concerning a new effort by the Veterans Administration to expand veterans' access to telehealth services around the country, mirrored what the Company has already been saying and validates the vision of the Company Founders.

President Trump alongside Department of Veterans Affairs Secretary, David Shulkin, at a Department of Veterans Affairs Telehealth Event in the White House, announced the VA's new Telehealth Services program.

The President said, "Today, I'm pleased to announce another historic breakthrough that will expand VA services to many more patients and veterans. We will do this through telehealth services." (emphasis added) https://www.whitehouse.gov/the-press-office/2017/08/03/remarks-president-trump-department-veterans-affairs-telehealth-event

Secretary Shulkin pointed out that the new effort aims to use telehealth services to help veterans seeking care 'anywhere to anywhere'. He said, "We'reremoving geography as a barrier so that we can speed up access to veterans and really honor our commitment to them." (emphasis added) https://www.whitehouse.gov/the-press-office/2017/08/03/remarks-president-trump-department-veterans-affairs-telehealth-event

Arturo 'Jake' Sanchez, CEO and Director, stated, "The similarities are striking. It certainly looks like we have been ahead of the curve here. But more importantly, the direction the President endorsed endorses our business direction and model. This means that under this administration all government based health services (i.e. DoD, VA, CMS) will consider the use of telehealth services as well. This in turn changes and creates regulations and legislation that soon reaches the private markets. This signals a boom for the space and a shift of funding to support the new agenda. The Company could not be in a better position.

From our experience, Telemedicine/telehealth many times may be the only way to deliver specialty care to rural populations. We believe that it will serve the VA well to help reduce the backlog by allowing our Veterans to get what they deserve - timely and quality specialty care.

We believe, to achieve their mission the VA will require private 3rd party telemedicine networks to control and reduce backlog. This announcement reaffirms our long-held focus on telemedicine/telehealth as the best vehicle to bring specialty quality medical care to all areas of need in rural and underdeveloped areas across the country. We are excited to be in the space and see more growth opportunities for our business."

About Medical Innovation Holdings, Inc.   

MIHI, a Colorado-based publicly traded company, owns and operates strategically aligned health care service companies focused on the delivery of clinical virtual medicine (health) as a way of bringing quality medical care to all areas of need including rural and underdeveloped areas across the country. Through our wholly owned subsidiary, 3Point Care, we provide personalized high-tech high-touch telemedicine encounters pairing our virtual health specialty doctors with traditional primary doctors utilizing nextgen virtual health technologies in order to connect a patient with a multi-disciplinary specialty clinical healthcare practice. Through our other companies and relationships we offer Affordable Care Organization (ACO) support, wellness and prevention, lab analysis and lab services, and remote diagnostic monitoring.

We serve a number of constituents and stakeholders interested in reducing the cost of care, enhancing the quality of care, promoting access to care, and maintaining the continuum of care.  

For more information on MIHI, please visit the Company's website at http://www.medicalinnovationholdings.com.

To be added to the Company investor email list, please email [email protected] with MIHI in the subject line.

To leave a message please call +1-866-883-3793 for Investor Relations.

FORWARD-LOOKING STATEMENTS 

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.


Investor Contacts:
[email protected]
+1-866-883-3793


SOURCE Medical Innovation Holdings, Inc.


These press releases may also interest you

at 07:35
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced the appointment of Dean J. Mitchell as chairman of its Board of Directors....

at 07:30
Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the first quarter ended March 31, 2024, and provided a...

at 07:30
Titan Medical Inc. ("Titan" or the "Company") , today reported financial results for the three months ended March 31, 2024. Recent Activities: On March 18, 2024, the Company announced it has entered into a definitive amalgamation agreement (the...

at 07:30
Avicanna Inc. ("Avicanna" or "Company) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce the completion of...

at 07:30
Subsidiary Reflexivity Research Initiates Coverage of TON Launch of Landmark ETPs: DeFi Technologies' subsidiary Valour Inc. unveils three groundbreaking Exchange Traded Products ("ETPs") including the Valour Internet Computer (ICP) ETP, Valour...

at 07:30
Moleculin Biotech, Inc., ("Moleculin" or the "Company"), a clinical stage pharmaceutical company...



News published on and distributed by: